The Dose Per Container Partnership (DPCP) explored decision making on dose per container (DPC) options in a number of countries to better understand the relationship between DPC and immunization system components. In Zambia, from January 2017 through August 2018, DPCP conducted implementation research using quantitative and qualitative methods, introducing 5-dose vials of measles-rubella (MR) vaccine to a select group of health facilities to assess the effects on the immunization system of reducing the DPC from the 10-dose vials in use. This report, written in 2020, details the findings from this research.
We strive to build lasting relationships to produce better health outcomes for all.
